Objective: To describe the treatment patterns for intravenous ganciclovir induction and
maintenance therapy in AIDS patients with cytomegalovirus (CMV) retinitis in five European …

Objectives: To compare the safety and efficacy of oral ganciclovir with intravenous
ganciclovir for the maintenance therapy of cytomegalovirus (CMV) retinitis in AIDS patients …

Background: The oral formulation of ganciclovir is approved at a dose of 3.0 g/day for
maintenance treatment of cytomegalovirus (CMV) retinitis following an initial induction …

OBJECTIVE: To recommend the appropriate use of oral ganciclovir as an alternative to
intravenous (iv) maintenance therapy for cytomegalovirus (CMV) retinitis in patients with …

Objective: To determine the efficacy and safety of intravitreal injection of ganciclovir for
active cytomegalovirus (CMV) retinitis in AIDS patients who are intolerant of systemic …

This prospective, clinical economic study was done to determine the cost impact of oral
compared with intravenous (IV) ganciclovir for the maintenance treatment of newly …

Cytomegalovirus retinitis is a major cause of morbidity in patients with AIDS. The
conventional treatment approach has involved insertion of a central venous catheter and …

OBJECTIVE: To report the clinical outcomes of highly active antiretroviral therapy (HAART)-
naïve, human immunodeficiency virus (HIV)-positive patients with newly diagnosed …

Purpose: Intravitreal injections of ganciclovir provide a useful adjunct or alternative treatment
for cytomegalovirus retinitis in AIDS patients when toxicity or progression is seen with …

OBJECTIVE: To review the pharmacology and pharmacokinetics of intravenous, oral and
intraocular ganciclovir, and to discuss the role of these various formulations in the …